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Summary
CD45 is a receptor-like protein tyrosine phosphatase
highly expressed on all nucleated hematopoietic cells.
We previously generated mice containing a point mu-
tation in the juxtamembrane wedge of CD45. Demon-
strating the critical negative regulatory function of
the wedge, the CD45 E613R mutation led to a lympho-
proliferative disorder (LPD) and a lupus-like autoim-
mune syndrome. Here we show the central role of B
cells in this phenotype. Genetic elimination of B cells,
but not T cells, ablates the LPD. In contrast to CD45-
deficient B cells, the E613Rmutation generates hyper-
responsive B cells. Comparison of CD45-deficient and
CD45 E613Rmice reveals dichotomous effects of these
mutations on B cell development. Together, the results
support a role for CD45 as a rheostat, with both posi-
tive and negative regulatory functions, that fine-tunes
the signal transduction threshold at multiple check-
points in B cell development.
Introduction
Tyrosine phosphorylation is regulated by the equilibrium
between protein tyrosine kinase and phosphatase activ-
ities. This balance actively determines the robustness of
responses from receptor-mediated signals as well as
the basal tone set by ligand-independent signals from
these same pathways (Veillette et al., 2002). Tonic sig-
nals are important for defining signal transduction
thresholds (Monroe, 2004). In the immune system, regu-
lation of this equilibrium allows for rapid responses to
foreign antigens, while perturbation of this balance can
have pathologic consequences.
The receptor-like protein tyrosine phosphatase
(RPTP) CD45 plays a central role in regulating phospho-
tyrosine levels. Studies of CD45-deficient T and B cell
lines (Justement et al., 1991; Koretzky et al., 1990; Pingel
and Thomas, 1989), mice (Byth et al., 1996; Kishihara
et al., 1993), and humans (Kung et al., 2000) reveal its
essential role as a positive regulator of antigen receptor
signaling. Both CD45-deficient mice and humans de-
velop severe combined immunodeficiency (SCID) with
defects in T and B cell development and function.
CD45 can also negatively regulate signals emanating
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Palo Alto, California 94305.from integrin and cytokine receptors (Huntington and
Tarlinton, 2004). In part, CD45 performs these diverse
functions by regulating the phosphorylation status of
src family kinases (SFKs) (Hermiston et al., 2003).
SFKs initiate immune responses via the antigen re-
ceptor and modulate growth factor, cytokine, and integ-
rin receptor-mediated signals (Lowell, 2004). Phosphor-
ylation of two key tyrosine residues regulates SFK
activity. Phosphorylation of the catalytic domain activa-
tion loop is essential for full kinase activity, whereas
phosphorylation of the C-terminal tyrosine decreases ki-
nase activity. CD45 can dephosphorylate this negative
regulatory tyrosine and generate a pool of ‘‘primed’’
SFKs capable of rapid activation upon receptor stimula-
tion (Ostergaard et al., 1989; Sieh et al., 1993). In some
cell types, CD45 inactivates SFKs by also dephosphor-
ylating the catalytic tyrosine (Ashwell and D’Oro, 1999;
Shrivastava et al., 2004). Whether CD45 positively or
negatively regulates SFKs likely depends upon its sub-
cellular localization relative to its substrate and the
phosphorylation state of the SFK (Thomas and Brown,
1999; Gupta and DeFranco, 2003).
CD45 consists of an extracellular, a transmembrane,
and a cytoplasmic region with two tandemly duplicated
phosphatase domains, D1 and D2. Only D1 is catalyti-
cally active. Multiple isoforms of CD45 are expressed
due to highly regulated alternative splicing of exons 4,
5, and 6, which encode a portion of the extracellular do-
main (Hermiston et al., 2003). The tight control of CD45
isoform expression suggests a regulatory role for the ex-
tracellular domain. Despite intensive efforts, a definitive
CD45 ligand has not been identified. This led to evalua-
tion of spontaneous isoform-differential homodimeriza-
tion as a potential means of regulation.
CD45 dimers have been identified by multiple meth-
ods (Felberg and Johnson, 1998; Takeda et al., 1992;
Dornan et al., 2002; Majeti et al., 2000; Xu and Weiss,
2002). To test the role of dimerization, a chimeric protein
containing the epidermal growth factor (EGF) receptor
extracellular and transmembrane domains fused to the
cytoplasmic domain of CD45 was introduced into
a CD45-deficient T cell line (Desai et al., 1993). Although
the chimera reconstituted the CD45-deficient state,
EGF-induced dimerization inhibited T cell receptor
(TCR)-mediated signal transduction. A potential molec-
ular explanation for dimer-mediated negative regulation
was suggested by the crystal structure of the mem-
brane-proximal D1 domain of the related phosphatase
RPTPa. It formed a symmetrical dimer in which the cat-
alytic site of one molecule was blocked by the juxta-
membrane wedge of its partner (Bilwes et al., 1996).
The phylogenetic conservation of the wedge in RPTP
and CD45 suggests a preserved evolutionary function
(Bilwes et al., 1996; Majeti et al., 1998). Introducing a
point mutation into the tip of the CD45 wedge abolished
the inhibitory effect of dimerization in a T cell line (Majeti
et al., 1998). The analogous point mutation introduced
into the germline of mice (denoted CD45 E613R) led to
a lymphoproliferative disorder (LPD) and a lupus-like au-
toimmune disease with autoantibody production and
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636Figure 1. The Wedge Motif Is Present in
CD45 and Essential in B Cells for Driving the
LPD
(A) Carbon atom trace of the RPTPa D1
domain (left), CD45 D1 and D2 domains (mid-
dle), and RPTPa and CD45 overlay (right). The
wedge motif is highlighted in ribbon form.
(B) Spleens were harvested from at least
three male and three female 6-month-old
mice of the depicted genotypes on a mixed
129/Sv-B6 genetic background. Splenic
weight was used as a measure of LPD. Anal-
ysis of variance (ANOVA) p < 0.0001.
(C) Representative histograms of spleno-
cytes from 6-month-old wt/TCRa and CD45
E613R/TCRa mice on a F10 B6 background
stained with anti-TER119 to detect erythroid
precursors.
(D) Enlarged LNs from the same animals were
stained with antibodies to CD19, IgM, CD43,
and CD5. Numbers represent the % CD5+
CD43Hi B1 cells in the CD19+ gate.immune complex-mediated glomerulonephritis (Majeti
et al., 2000).
It was unclear whether the CD45 E613R phenotype
was due to the direct effect of the wedge mutation in
each hematopoietic lineage or whether dysregulation
in a single cell type led to the secondary activation of
other lineages. We hypothesized that the phenotype
was driven primarily by dysregulation of phosphatase
activity in T cells (Majeti et al., 2000). T cells undergo
an activation-induced switch from high to low molecular
weight (MW) isoforms, while B cells express primarily
the high MW isoform RABC. Since our prior studies
showed that smaller isoforms dimerize more efficiently
than large, we proposed that enhanced dimerization of
the RO isoforms would titrate the available CD45 cata-
lytic activity, thereby contributing to cessation of the pri-
mary T cell response. Here, we test this hypothesis by
genetically eliminating T cells, B cells, or T and B cells
in CD45 E613R mice. To our surprise, elimination of B
cells, but not T cells, ablated the LPD. The wedge muta-
tion leads to B cell hyperresponsiveness and altered B
cell development. These B cell alterations were opposite
those found in CD45-deficient mice. Together, the datasupport a model in which CD45 functions as a rheostat
to define signal transduction thresholds in B cells and
identify the wedge as a critical regulator of this rheostat.
Results
B Cells Are Required for the Wedge-Induced LPD
The crystal structure of the RPTPa D1 domain (Bilwes
et al., 1996), together with molecular modeling and the
functional effects of forced CD45 dimerization in chime-
ric EGFR-CD45 molecules (Majeti et al., 1998), prompted
us to generate the CD45 E613R mice (Majeti et al., 2000).
The recent crystal structure of the cytoplasmic region of
CD45 confirms the presence of a wedge associated with
the D1 domain (Nam et al., 2005). Using the published
coordinates for CD45 and RPTPa, we find that the con-
formations of the wedge and D1 domains of both pro-
teins are very similar (Figure 1A). Here, we begin to ex-
plore the role of the wedge in individual hematopoietic
lineages.
To address which cell(s) were required for the LPD,
CD45 E613R mice on a mixed 129/Sv-C57Bl/6 (B6)
genetic background were bred with TCRa2/2, Igm2/2,
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cells, or T and B cells, respectively. Using splenic weight
and lymphadenopathy of 6-month-old mice as a mea-
sure of LPD, we found that the absence of a/b T cells
had no effect on the incidence of the LPD, autoantibody
production, or glomerulonephritis. However, elimination
of B cells or T and B cells in CD45 E613R mice ablated
the LPD and autoimmune disease (Figure 1B; data not
shown), demonstrating the critical role of B cells in driv-
ing the E613R phenotype.
The considerable heterogeneity in disease onset in
CD45 E613R mice on a mixed genetic background ini-
Figure 2. CD45 E613R B Cells Are Hyperresponsive to BCR, CD40,
and LPS Stimulation
Splenic B cells, purified by negative selection from 8-week-old B6
CD45 E613R or wt mice, were stimulated for 48 hr with (A) goat
anti-IgM F(ab’)2, (B) anti-CD40, or (C) LPS. Data represent the aver-
age counts per minute (CPM) of 3H incorporation from four individual
mice of each genotype 6 SEM and are representative of at least
three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.tially complicated functional studies. Therefore, we
backcrossed the CD45 E613R mice for nine generations
onto a B6 genetic background. The B6 E613R mice uni-
formly developed mild splenomegaly and lymphade-
nopathy between 12 and 16 weeks of age. Interestingly,
these mice did not develop autoantibodies or glomeru-
lonephritis, indicating that genetic modifiers play a role
in the CD45 E613R phenotype (data not shown). As in
the mixed background, the LPD was ablated in B6
CD45 E613R Igm2/2 and Rag2/2 mice, but not in
TCRa2/2 animals (data not shown). The LPD in E613R
TCRa2/2 mice was due to extramedullary hematopoie-
sis with a 15-fold increase in Ter119+ cells in the spleen
and expansion of B1 cells in the spleen and lymph node
(LN) (Figures 1C and 1D). To eliminate the confounding
effects of genetic modifiers, all subsequent analyses of
B cell function were performed on animals on a R F9
B6 background.
Hyperresponsive B Cells in CD45 E613R Mice
The LPD and autoimmune disease in CD45 E613R mice
phenocopies the effects of mutations in negative regula-
tors of BCR signaling including Lyn (Chan et al., 1997;
Hibbs et al., 1995), CD22 (O’Keefe et al., 1996), and
SHP-1 (Cyster and Goodnow, 1995). Since the latter mu-
tations are associated with intrinsic B cell hyperrespon-
siveness, we tested the proliferative response of B cells.
Contrasting the previously reported poor proliferative
response of CD45-deficient (knock-out, KO) B cells
(Byth et al., 1996; Kishihara et al., 1993), the proliferation
of CD45 E613R B cells to F(ab’)2 anti-IgM stimulation
was enhanced (Figure 2A). Because CD45 or its sub-
strate Lyn have been implicated in CD40 and LPS signal-
ing (Tan et al., 2000; Yazawa et al., 2003), we tested the
responsiveness of CD45 E613R B cells to these stimuli
and also found hyperresponsiveness (Figures 2B and
2C).
A potential explanation for the enhanced responsive-
ness could be the presence of inappropriately activated
cells due to the LPD. Similar to the mixed background
(Majeti et al., 2000), activated B cells accumulated in
the LN and spleen of aged F9 B6 CD45 E613R mice
(see Figures S1A and S1B in the Supplemental Data
available with this article online). However, cell-surface
levels of IgM, CD40, B7.1, B7.2, MHCII, and CD69 on
CD19+ B cells were equivalent in 6- to 10-week-old
CD45 E613R and wt mice (Figures S1A and S1B; data
not shown). CD45 cell-surface levels and isoform usage
were also indistinguishable (Figures S1C and S1D).
Exaggerated BCR Signaling in CD45 E613R B Cells
BCR-induced signals through the MAPK kinase path-
way are decreased in CD45 KO mice (Cyster et al.,
1996). In contrast, BCR stimulation of CD45 E613R B
cells resulted in enhanced ERK phosphorylation (Fig-
ure 3A). Interestingly, basal levels of phospho-ERK
were indistinguishable from wt mice (Figure 3A), remi-
niscent of mice deficient in the CD45 substrate Lyn
(Chan et al., 1997) and opposite to the constitutive basal
phosphorylation of ERK in mice expressing an activated
form of Lyn (Hibbs et al., 2002).
In B cells, deficiency of the negative regulatory pro-
teins Lyn, CD22, or SHP-1 results in enhanced calcium
flux (Cornall et al., 1998), while absence of CD45 leads
Immunity
638Figure 3. Altered BCR Signal Transduction in CD45 E613R B Cells
(A) Purified B cells were stimulated with 20 mg/ml goat anti-mouse IgM F(ab’)2 for the times indicated, whole-cell lysates (WCL) were prepared,
and phospho-ERK was assessed by immunoblotting. Blots were stripped and total ERK levels were assessed. Quantitative luminescence of the
lower phospho-ERK band, normalized to total ERK levels in the same lane, is depicted. Data from three independent analyses are quantitated in
the histogram. Error bars depict SEM. *p < 0.05; **p < 0.01.
(B) Intracellular calcium levels of Fluo3-AM-loaded B cells from 8-week-old CD45 KO, wt, and E613R mice were monitored before and after ad-
dition of goat anti-mouse IgM F(ab’)2. Results are representative of four independent experiments.
(C–E) Intracellular calcium levels of CD45 E613R/IgHEL and wt/IgHEL B cells were monitored before and after addition of the indicated concen-
trations of the HEL antigen (C and D) or ionomycin (E).
(F and G) Lyn was immunoprecipitated from WCLs from purified CD45 E613R and wt B cells and immunoblotted with mAb to the autocatalytic
tyrosine (F) or negative-regulatory tyrosine (G). Blots were stripped and probed for Lyn as a control.to diminished calcium flux (Cyster et al., 1996). To ex-
plore CD45’s potential ability to both positively and neg-
atively impact antigen-induced signals, we directly com-
pared BCR-induced calcium mobilization in CD45 KO,
wt, and E613R B cells. Whereas calcium flux was dimin-
ished in CD45 KO B cells, the E613R response was
heightened and sustained (Figure 3B).
To determine whether these differences were due to
the direct effects of the E613R mutation or simply to dif-
ferences in responses of B cells at different develop-
mental stages, we introduced the Ig transgene specific
for the antigen hen egg lysozyme (HEL) (Goodnow
et al., 1988) into B6 CD45 E613R and wt mice, generatinganimals with uniform B cell repertoires. Stimulation of
CD45 E613R/IgHEL B cells with low concentrations of an-
tigen resulted in delayed but more sustained calcium
flux relative to wt/IgHEL B cells (Figure 3C). At saturating
concentrations, HEL induced higher amplitude and
more sustained responses in E613R B cells (Figure 3D).
Responses to ionomycin were similar in both groups
(Figure 3E). Collectively, the data support a role for
CD45 as a rheostat capable of both positively and neg-
atively impacting signaling thresholds in B cells.
CD45 primarily inhibits SFKs in B cells by dephos-
phorylating both autocatalytic and negative regulatory
tyrosines (Katagiri et al., 1995; Shrivastava et al., 2004).
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is hyperphosphorylated and its negative regulatory tyro-
sine is hypophosphorylated in CD45 KO mice (Shrivas-
tava et al., 2004). In contrast, Lyn’s autocatalytic tyro-
sine was hypophosphorylated (Figure 3F) while the
negative regulatory C-terminal tyrosine was hyperphos-
phorylated in both resting and activated CD45 E613R B
cells (Figure 3G). This pattern is consistent with inhibi-
tion of Lyn kinase activity and may explain why the
E613R phenotype mirrors that of Lyn-deficient mice.
Dichotomous Effects of CD45 Deficiency
and the CD45 E613R Mutation on Peripheral
B Cell Development
Signal strength through the BCR plays a critical role in
regulating decision points during B cell development
(Monroe, 2004). The opposing effects of CD45 defi-
ciency and the E613R mutation on BCR-mediated sig-
nals present a unique opportunity to explore this issue
directly. Comparison of B cell development in 8-week-
old B6 CD45 KO, wt, and E613R mice failed to reveal dif-
ferences in lymphoid organ size or in the absolute num-
ber of nucleated cells in the bone marrow, blood, LN,
and spleen (data not shown). However, a consistent de-
crease in the proportion and absolute number of CD19+
B cells, with a concomitant expansion of CD3+ cells, was
noted in CD45 E613R LN and spleen (Figure 4A, Fig-
ure S2A; data not shown). Consistent with prior reports
(Byth et al., 1996; Kishihara et al., 1993), CD45 deficiency
had the opposite effect with increased CD19+ B cells
(Figure 4A).
To further interrogate the role of CD45 in splenic
B cell development, we used CD21 and CD23 stain-
ing (Figure 4B) to differentiate newly formed (NF;
CD212CD232), transitional type 2/follicular (T2/FO;
CD21Lo-HiCD23Hi), and marginal zone (MZ; CD21hiCD232)
B cells. CD19+CD212CD232 cells were increased 2-fold
in CD45 KO mice and almost 4-fold in CD45 E613R
mice. Because B1 cells are also in this gate and were in-
creased in CD45 E613R/TCRa2/2 mice, we further ana-
lyzed this population with antibodies to CD5, CD43,
HSA, and AA4.1. There was a small but significant in-
crease in the frequency and absolute number of CD5+,
CD43+, IgMHi B1 cells in the spleens of E613R mice
(Figure 4C). However, HSA+AA4.1+ NF cells accounted
for the majority of CD212CD232 cells in both CD45 KO
and E613R mice (Figure 4C, data not shown).
Our initial evaluation of CD21 3 CD23 staining also
suggested that there was a previously unreported and
dramatic expansion of MZ B cells in CD45KO mice and
a paucity of these cells in CD45 E613R mice (Figure 4B).
Confounding this analysis, however, was the apparent
downregulation of CD21 in E613R mice, despite equiva-
lent levels of CD19, CD23, and IgM relative to wt mice
(Figure 4B, Figure S3A). To more accurately evaluate
MZ and FO B cell development, we used IgM and IgD
staining to differentiate T1 (IgMHiIgDLo), T2 (IgMHiIgDHi),
and mature FO (IgMLoIgDHi) B cells (Figure 4D). CD1d
staining was then used to delineate T1 cells into mature
MZ cells (IgMHiIgDLoCD1dHi) and immature cells
(IgMHiIgDLoCD1dLo) and to divide T2 cells into FO pre-
cursors (FOp; CD21IntCD23+IgMHiIgDHiCD1dLo) and MZ
precursors (MZp; CD21HiCD23+IgMHiIgDHiCD1dHi) (Pillaiet al., 2004). This confirmed a 10-fold increase in MZ pre-
cursors and a 3-fold increase in mature MZ B cells in
CD45 KO mice (Figures 4D and 4E). Despite downregu-
lation of CD21 (Figure S3), there was no significant dif-
ference in the proportion and absolute number of
E613R MZ B cells as defined by CD1dHi staining (Figures
4C–4E). We next examined follicular B cell development.
However, the proportion and absolute number of both
precursor and mature FO cells was decreased in CD45
KO and E613R mice (Figures 4D and 4E).
The wedge model predicts that the E613R mutation
should act dominantly. To test this, we examined B
cell development in 8-week-old CD45 E613Rm/m,
E613Rm/+, and CD45+/+ mice. As predicted, B cell devel-
opment in heterozygous mice was intermediately af-
fected (Figure S2), further supporting CD45’s role as
a rheostat that modulates signaling thresholds at multi-
ple developmental checkpoints.
CD45 Impacts Bone Marrow B Cell Development
The proportion and absolute number of bone marrow
CD19+ B cells was increased in CD45 E613R mice, but
was equivalent between CD45 wt and KO mice (Fig-
ure S4A). Confirming a recent report, CD19+CD43+
IgM2IgD2 pro and CD19+CD43+IgM2IgD2 pre B cells
were expanded in CD45 KO mice (data not shown).
The absolute number, but not percentage, of pro and
pre B cells was modestly increased in E613R mice (Fig-
ures S4B and S4C; data not shown). More striking was
the increase in CD19+CD432IgMHiIgDLo immature B
cells and the decrease in mature, recirculating B cells
in CD45 E613R marrow (Figures S4B and S4C).
CD45 Influences B1 Cell Production
B1 cells link the innate and adaptive immune systems.
Accumulating data suggest that increased signal
strength promotes B1 versus B2 cell development
(Lam and Rajewsky, 1999; Niiro and Clark, 2002). While
there was no difference in the total peritoneal cellularity
of 8-week-old B6 CD45 E613R mice, there was a marked
increase in cells with enhanced forward and side scatter
properties that were CD19+, B220int, CD5+, Mac-1+,
CD43+, CD232, IgMHi, and IgDLo (Figure 5A; data not
shown), phenotypic characteristics of the B1 cell line-
age. Concomitant with the increase in B1 cells, perito-
neal CD45 E613R B2 cells were decreased (Figures 5A
and 5B). B1 cells were also increased in the spleen
(Figure 4C) and LN (Figure 5C) in CD45 E613R mice.
Confirming prior reports, 8-week-old CD45 KO mice
had abundant B2 and a paucity of B1 B cells in the peri-
toneum, spleen, and LN (Figure 5B; Byth et al., 1996;
Cyster et al., 1996). These data suggest that titration of
CD45 phosphatase activity is essential at the B1 versus
B2 lineage decision checkpoint.
In the absence of previous antigen stimulation, B1
cells produce most of the circulating IgM. These natural
antibodies are low affinity with specificities that include
carbohydrate and self antigens (Hayakawa et al., 1984).
We evaluated serum immunoglobulin levels from 8-
week-old F9 B6, 129/Sv, and BALB/c CD45 E613R and
wt littermates. E613R mice on each genetically homog-
enous background had 10-fold increases in serum IgM
levels (Figure 5C). Differences in other immunoglobulin
Immunity
640Figure 4. Dichotomous Effects of CD45 Deficiency and the CD45 E613R Mutation on Conventional B Cell Development
(A) Splenocytes from 8-week-old B6 CD45 KO, wt, and E613R mice were stained with a mAb to CD19. The percentage (left) and absolute number
(right) of CD19+ lymphocytes are shown.
(B) Representative FACS analysis of splenocytes stained with mAbs to CD19, CD21, and CD23. Numbers in each gate represent % CD19+ cells.
(C) CD19+CD212CD232 cells were stained with anti-CD5, CD43, AA4.1, and/or HSA to differentiated NF from B1 B cells. The percent (top) or
absolute number (bottom) of NF (HSA+AA4.1+CD52CD432) and B1 (HSA2AA4.12CD5+CD43+) in the CD19+CD212CD232 gate is indicated.
(D) Representative FACS analysis of splenocytes stained with mAbs to CD19, IgM, IgD, and CD1d. Numbers in gates in left column represent cells
in the CD19+ gate. The upper left quadrant identifies mature FO cells, the upper right depicts T2 cells, and the lower right identifies T1 cells. Mid-
dle column depicts CD1d reactivity of cells in the T1 gate. Percentage of MZ (CD1dhi) and NF (CD1dlo) cells in the grandparent CD19+ gate is
noted. The right column depicts CD1d reactivity of cells in the T2 gate. Percentage of MZ precursor (MZp, CD1dhi) and FO precursor (FOp,
CD1dlo) cells in the grandparent CD19+ gate are noted.
(E) Quantification of splenic B cell subsets as labeled in (D). Data in (A)–(E) represent a minimum of three independent experiments, each includ-
ing at least three mice per genotype. Error bars depict SEM. Student’s t test was used to determine significance of CD45 E613R or KO compared
to wt. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.isotypes were less pronounced, including IgA (data not
shown). Further supporting B1 cells as the source of
the elevated IgM, restriction of the B cell repertoire inCD45 E613R/IgHEL mice prevented the increase in B1
cells and resulted in normalization of serum IgM levels
(data not shown).
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641Figure 5. Increased B1 and Decreased B2
Cell Production in CD45 E613R Mice
(A) FACS analysis of peritoneal lavage from
8-week-old B6 wt and CD45 E613R mice.
Top panel depicts forward versus side scat-
ter profiles. Gated cells were subsequently
phenotyped by mAbs to CD19, B220, IgM,
IgD, CD5, CD23, CD43, and Mac1 in the bot-
tom panel (and data not shown). Numbers re-
flect percentage of lymphocytes with a B1
(CD5intIgM+) or B2 (CD52IgM+) phenotype.
(B) Comparison of B1 versus B2 development
in peritoneal lavage of B6 CD45 KO (white), wt
(gray), or E613R (black) 8-week-old mice.
(C) B1 cells are increased in LNs from B6
8-week-old CD45 E613R relative to wt con-
trol animals. Data in (C) and (D) represent
mean 6 SEM for 6–12 mice per genotype.
(D) Serum IgM levels are increased in 8-week-
old CD45 E613R mice on F9 B6, BALB/c, and
129/Sv backgrounds as determined by
ELISA. Each point represents an individual
wt (open shapes) or mutant (closed shapes)
animal. ****p < 0.0001.T-Independent Antigen Exposure Leads
to Increased Responses and LPD Exacerbation
in CD45 E613R Mice
To evaluate the functional competence of CD45 E613R B
cells, 8-week-old mutant and wt mice were immunized
with nitrophenol (NP) conjugated to the thymus-
independent (TI) type 2 antigen Ficoll (NPF). Anti-Ficoll
IgM responses were significantly enhanced in E613R
mice relative to wt controls (Figure 6A).Antigen encounter can exacerbate LPD and autoim-
mune diseases (Wucherpfennig, 2001). CD45 E613R
mice injected with NPF exhibited a significant increase
in splenic weight relative to controls (Figure 6B). This
was associated with expansion of the splenic white
pulp due to an increase in the proportion and absolute
number of B1, activated B2, and syndecan+, IgM+
plasma cells (Figure 6C; data not shown). These data
suggest that the CD45 wedge plays a critical role in
Immunity
642Figure 6. TI Antigen Challenge Exacerbates the CD45 E613R LPD
(A) 8-week-old B6 CD45 E613R or wt mice were immunized with NPF, sera were obtained at the indicated time points, and NPF-specific IgM
levels were determined by ELISA (average6 SEM from 23 wt and 25 CD45 E613R sex-matched animals immunized in two independent experi-
ments). Student’s t test was used to compare the mean OD at each time point. **p < 0.01; ****p < 0.0001.
(B) Immunization with a TI antigen accelerates the LPD. Spleens were harvested 8 weeks postintraperitoneal injection with PBS or NPF and
weighed (n = 20 mice/genotype). Error bars depict SEM. ****p < 0.0001.
(C) Increased plasma cell production in CD45 E613R mice immunized with a TI antigen. Left, representative FACS plots of total splenocytes or
CD19-gated cells from mice immunized in (A). Right, mean6 SEM syndecan+ cells in the CD19+ gate (n = 5 mice/genotype). **p < 0.01. There was
no significant difference in plasma cell numbers in unimmunized animals (data not shown).negative regulation of TI immune responses and impli-
cate antigen encounter in the LPD.
Restricting the B Cell Repertoire Rescues CD45
E613R B Cell Development
The B cell hyperresponsiveness and increase in B1 cells
suggests that the E613R mutation increases BCR signal
strength. The decrease in mature FO B cells was thus ini-
tially puzzling since this is most often associated with in-
efficient BCR signals. Alternatively, this decrease could
reflect enhanced deletion, either due to excessive tonic
signals through the BCR and/or excessive ligand-depen-
dent signals, stimulated by encounter with self-antigen.
To differentiate these possibilities, we generated B6
CD45 E613R and wt mice expressing the IgHEL transgene.
Contrasting the previously reported 3-fold decrease in
B cells in CD45 KO/IgHEL mice (Cyster et al., 1996), restric-
tion of the B cell repertoire in CD45 E613R/IgHEL mice re-
stored B cell numbers to levels consistently greater than
those observed in wt/IgHEL mice (Figure 7A).
We speculated that the expansion of immature B cells
in CD45 E613R mice could be a compensatory attempt to
maintain homeostasis. Consistent with this notion, re-
stricting the B cell repertoire resulted in a decrease in
NF CD212CD232IgMHi splenic B cells and normalization
of B cell development in the bone marrow in CD45
E613R/IgHEL mice relative to wt controls (Figures 7B–7D;
data not shown). Interestingly, splenic weight in aged
CD45 E613R/IgHEL mice also normalized (data not
shown), suggesting that a restricted B cell repertoire pre-
cludes development of the LPD.The most striking difference revealed by CD21 3
CD23 staining was the enhanced differentiation of FO
B cells at the expense of MZ B cells in CD45 E613R
mice (Figure 7B). It has been suggested that the lack
of ligand encounter limits the transition from the T2 to
mature FO B cells in wt/IgHEL mice (Pillai et al., 2004).
We examined this transition point and noted bimodal
peaks in IgMa expression in E613R/IgHEL B cells but
not in wt/IgHEL controls (Figure 7C). There were no ap-
preciable differences in B7.1, B7.2, or CD69 expression
(data not shown), suggesting that the decrease in IgMa
expression was not secondary to inappropriate activa-
tion of E613R B cells. However, the IgMa Lo cells were
CD23Hi, CD21Lo, IgDa Hi, phenotypic characteristics of
mature FO B cells (Figures 7B and 7C). These data sup-
port a model in which weak signals favor MZ B cell de-
velopment, while strong signals, due to ligand encounter
or altered tonic signals, favor FO B cell development.
These data also suggest that the decrease in T2 and
FO B cells in nontransgenic E613R mice is not due to
a developmental block, but rather reflects enhanced de-
letion secondary to ligand-dependent signals during en-
dogenous or exogenous antigen encounter.
Chronic Antigen Exposure Leads to Decreased
CD45 E613R/IgHEL B Cells
Chronic exposure of developing wt/IgHEL B cells to
a strong stimulus such as membrane bound antigen
leads to deletion, while exposure to soluble HEL
(sHEL) leads to anergy (Goodnow et al., 1988; Hartley
et al., 1991). These different fates have been attributed
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(A) Histograms of CD19+ splenocytes in B6 wt or CD45 E613R in the presence or absence of the IgHEL transgene. Graphs depict mean percentage
(left) or absolute number (right) of CD19+ cells in the lymphocyte gate.
(B) B cell development in B6 CD45 E613R/IgHEL and wt/IgHEL mice. Anti-CD21 and CD23 staining of cells in the CD19+ gate is shown. Numbers
represent the percentage of CD19+ cells with a NF (CD212, CD232), T1/MZ (CD21hiCD23Int-Lo), or T2/FO (CD21int-hi,CD23hi) phenotype.
(C) Overlay of CD45 E613R/IgHEL and wt/IgHEL B cells in the T2/FO CD19+CD23hi gate were further differentiated into T2 and mature FO sub-
groups by IgMa staining.
(D) Quantification of splenic B cell subsets as labeled in (B) and (C). Left, %, and right, absolute numbers, of splenocytes in each subset.
(E) Chronic antigen exposure leads to decreased CD19+ B cells in CD45 E613R/IgHEL/sHEL mice. Left, representative histograms, middle, %, and
right, absolute number, of CD19+ splenocytes from mice of the indicated genotypes. Data (A)–(E) represent three independent experiments, each
including three mice per genotype. Error bars depict SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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644to differences in BCR signal strength generated by
membrane versus soluble antigen. For example, chronic
exposure to sHEL in CD45 KO/IgHEL mice rescues
splenic B cell development (Cyster et al., 1996), while
loss of the negative regulator SHP-1 in IgHEL/sHEL
mice leads to enhanced B cell deletion (Cyster and
Goodnow, 1995). To test whether the wedge mutation
alters the threshold for triggering arrested development,
deletion, or anergy, we generated CD45 E613R/IgHEL/
sHEL mice. Chronic antigen exposure led to decreased
E613R splenic B cells (Figure 7E). The number of IgHEL
pre-B cells was equivalent in mutant and wt animals, in-
dicating that the decrease in mature splenic E613R/
IgHEL B cells occurred after cell-surface IgM expression
and encounter with autoantigen.
Discussion
We analyzed the effects on the B cell lineage of a point
mutation in the tip of the CD45 juxtamembrane wedge.
The functional and physiologic consequences of the
E6513R mutation in B cells are nearly opposite to those
observed in CD45-deficient mice. Demonstrating a pos-
itive regulatory role for CD45 in BCR signaling, CD45 KO
B cells are hyporesponsive to BCR stimulation and dis-
play reduced calcium responses (Byth et al., 1996; Kish-
ihara et al., 1993). Associated with these biochemical
abnormalities is a modest expansion of pro-B cells, a de-
crease in mature recirculating cells in the bone marrow,
a block in the transition from T2 to mature FO B cells, en-
hanced MZ cell production, and decreased B1 cells. In-
stead of generating anergic B cells as in wt mice, chronic
antigen exposure rescues the development of CD45 KO/
IgHEL B cells (Cyster et al., 1996). In contrast, analysis of
CD45 E613R B suggests a negative regulatory role for
the wedge. CD45 E613R B cells are hyperproliferative
and have augmented calcium and MAPK responses. B
cell development is altered with expansion of immature
B cells in the marrow, a block at the T1/NF to T2 and T2
to mature checkpoints in the spleen, and augmented B1
cell production. Chronic antigen exposure results in en-
hanced deletion of E613R/IgHEL B cells. Consistent with
these differences, CD45 KO and E613R mutations have
opposing effects on the phosphorylation status of the
SFK lyn.
These seemingly dichotomous functions of CD45 can
be reconciled by hypothesizing that CD45 functions as
a rheostat to fine-tune phosphotyrosine, and thus signal
transduction thresholds, in B cells. Thus, loss of CD45
phosphatase activity leads to an elevated BCR thresh-
old, while disrupting the wedge leads to a decreased
BCR threshold. Central to this hypothesis is the follow-
ing question: How does the E613R mutation affect
CD45 phosphatase activity? The recent crystal structure
of the cytoplasmic region of CD45 confirms the pres-
ence of a wedge associated with the D1 phosphatase
domain in a conformation nearly identical to that of
RPTPa (Figure 1A), but challenges the notion that the
wedge can interact with the partner D1 catalytic site dur-
ing dimerization (Nam et al., 2005). In the observed crys-
tallized conformations, the steric hinderance generated
by the angle between the closely interacting D1 and D2
domains precludes inhibition of phosphatase activity bythe wedge during spontaneous or regulated dimeriza-
tion (Nam et al., 2005).
Can we reconcile our data with these structural find-
ings? The conservation of the wedge in CD45 and the ro-
bust phenotype generated by a single point mutation in
vivo strongly argues that the wedge is functionally im-
portant. One possibility is that our model is incorrect
and that the wedge modulates CD45 activity by mecha-
nisms that do not involve its interaction with the catalytic
site of its partner during dimerization. This could involve
regulating interactions with other proteins, dictating its
subcellular localization, and/or mediating its access to
substrate. Although we are exploring these possibilities,
to date, support for any of these mechanisms has not
been identified. Alternatively, the CD45 crystal structure
does not necessarily preclude the possibility that the
wedge could negatively regulate CD45 during dimeriza-
tion. The crystal structures obtained for CD45 represent
only one selected conformation that could be crystal-
lized and do not eliminate the possibility that other con-
formations, including intermolecular dimers, also exist.
Indeed, as noted above, extensive evidence for CD45
dimers exists. One can speculate that the CD45 D2 do-
main might undergo conformational change or move-
ment under certain physiologic conditions that would
eliminate its steric hinderance of dimerization.
The extracellular and transmembrane domains of
RPTPs may be critical for regulating dimerization and,
thus, phosphatase activity. Mutational analyses demon-
strated that the transmembrane domain of RPTPa is suf-
ficient for dimerization (Tertoolen et al., 2001). Similarly,
the extracellular and transmembrane domains of CD45
are sufficient for dimerization, while the wedge and in-
tracellular domains are dispensable (Xu and Weiss,
2002). Interestingly, three different techniques demon-
strated that full-length RPTPa exists predominantly as
dimers in living cells (Tertoolen et al., 2001). A cyste-
ine-trapping approach revealed that enzyme activity
was influenced by rotational coupling, regulated in part
by the D2 domain, of the constitutive dimers within the
cell membrane (van der Wijk et al., 2003). Oxidative
stress induces a large conformational change in the
RPTPa D2 domain that stabilizes dimer formation (van
der Wijk et al., 2003). It is tempting to speculate that sim-
ilar mechanisms may operate to overcome the confor-
mational restraints seen between D1 and D2 in the
CD45 crystal structure.
Because small MW CD45 isoforms dimerize more effi-
ciently than large (Xu and Weiss, 2002), we were sur-
prised that B cells, which express primarily the largest
isoforms, were central to the E613R phenotype. This ob-
servation is not necessarily incompatible with our initial
model. While their formation is albeit less efficient,
dimers of the large MW CD45 isoforms have been readily
detected in vivo (Xu and Weiss, 2002). We speculate that
B cells may be more dependent upon the absolute levels
of CD45 phosphatase activity than other lineages. Sup-
porting this idea are findings from CD45 KO mice recon-
stituted with transgenes expressing various CD45 iso-
forms (Ogilvy et al., 2003; Tchilian et al., 2004). Very
low levels of CD45 partially rescued T cell production
and proliferation. In contrast, even the most highly ex-
pressed transgenes failed to restore B cell function.
Our data are consistent with a model in which net
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645phosphatase activity defines basal, or tonic, signaling
thresholds in B cells. We hypothesize that the CD45
wedge functions to finely tune these thresholds. Given
the high expression levels of CD45, even modest
changes in phosphatase activity could have significant
consequences. The intermediate B cell phenotype of
mice heterozygous for the CD45 KO or E613R mutations
supports this notion. Moreover, the predominance of B
cells for the LPD phenotype does not preclude a func-
tional role for the E613R mutation in other lineages.
For example, CD45 E613R T cells are hyperresponsive
to stimulation and undergo altered thymic development
in a TCR transgenic system (data not shown).
What are the molecular mechanisms underlying the
hyperresponsiveness of CD45 E613R B cells? Dysregu-
lation of SFKs, particularly Lyn, appears to contribute to
the E613R B cell phenotype. While enhanced positive
regulation of Lyn is possible, phenotypically the CD45
E613R mice are much more similar to Lyn-deficient
mice than mice expressing a constitutively active form
of Lyn. This suggests that Lyn is functionally inactive in
the E613R B cells and implies that both the catalytic
and negative regulatory tyrosines may be targets
for CD45. Precedence for this idea exists. Analysis of
CD45-deficient B cell lines and mice has demonstrated
that Lyn is constitutively active due to hyperphos-
phorylation of the autocatalytic site (Katagiri et al., 1995;
Shrivastava et al., 2004). In contrast, Lyn is hypophos-
phorylated at the autocatalytic tyrosine and hyperphos-
phorylated at the negative regulatory tyrosine in CD45
E613R B cells, a pattern indicative of Lyn inactivation.
Together, these findings suggest that CD45’s primary
function is to negatively regulate this SFK in B cells.
While Lyn clearly has both positive and negative regula-
tory functions, it is its role in attenuating BCR signals
that is unique and nonredundant. Our data are consis-
tent with a model in which the wedge normally functions
to negatively regulate CD45 phosphatase activity,
thereby enabling maximal Lyn activation and its subse-
quent functions as a negative regulator of BCR signals.
Comparison of B cell development in CD45 KO and
E613R mice presents a unique opportunity to explore
the factors regulating key developmental checkpoints.
The relative contributions of ligand-dependent and
-independent signals in B cell development are an area
of intense investigation. Clearly, a functional BCR is es-
sential for B cell survival (Kraus et al., 2004), presumably
due to basal signals generated in a ligand-independent
fashion. However, it is less clear whether tonic signals
are required only for cell maintenance or whether they
also contribute to cell fate decisions (Monroe, 2004).
The enhanced production of mature FO B cells in
CD45 E613R/IgHEL mice, in the absence of antigen, sup-
ports the latter conclusion. The block in the T1 to T2/
mature FO steps in nontransgenic CD45 E613R mice
and the rescue of this in CD45 E613R/IgHEL mice indi-
cates that ligand-dependent signals are also important.
A role for negative selection at both the T1 to T2 and the
T2 to mature checkpoints teleologically makes sense
since the antigens that T2 cells encounter as they enter
the follicle differ from those seen in the PALS. A second
area of controversy has focused on whether a weaker or
stronger signal facilitates MZ development (Monroe,
2004). The lack of expansion of MZ cells in CD45E613R mice and the 10-fold increase in CD45 KO cells
favors the former hypothesis. Finally, comparison of
CD45 KO and E613R mice supports a role for increased
BCR signal strength in B1 cell development (Niiro and
Clark, 2002). Normalization of this cell population in
CD45 E613R/IgHEL mice supports a role for antigen en-
counter in the positive selection of B1 cells. Taken to-
gether, the dichotomy of the CD45 KO and E613R phe-
notypes support CD45’s function as a rheostat, setting
signal transductions thresholds at multiple checkpoints
in B cell development. Moreover, the data identify an im-
portant negative regulatory role for the juxtamembrane
wedge in B cells.
Experimental Procedures
Modeling Studies
The structures of CD45 and PTPa were modeled with PDB Viewer
software and the published coordinates of CD45 and PTPa in the
Protein database.
Mice
CD45 E613R 129xB6 hybrid background mice (Majeti et al., 2000)
were bred with Rag1-, TCRa-, or Igm-deficient B6 mice (Jackson
Laboratories). Subsequent experiments employed CD45 E613R
and wt mice backcrossed at least nine generations onto B6,
BALB/C, or 129/Sv backgrounds. B6 IgHEL (MD4 line) and sHEL
(ML5 line) transgenic mice were obtained from J. Cyster. B6 CD45
KO (exon 6 disruption) mice were obtained from E. Brown. All ani-
mals were housed in a specific pathogen-free facility at UCSF ac-
cording to University and National Institutes of Health (NIH) guide-
lines.
B Cell Proliferation Assays
Splenic B cells, purified by negative selection by CD11b- and CD43-
conjugated magnetic beads (Miltenyi Biotec, Auburn, CA), were rou-
tinely R92% CD19+. Cells, plated in triplicate at 2 3 105 cells/well,
were stimulated with goat anti-mouse F(ab’)2 anti-IgM (Jackson Im-
munochemicals), anti-CD40 (BD), IL4 (BD), or LPS (E. coli serotype
0111:B4, Sigma). [3H] thymidine (1 mCi/well) was added during the
final 12 hr of culture. [3H] incorporation was determined at hour 48
with a Betaplate reader (PerkinElmer).
Western Blots and Immunoprecipitation
Purified splenic B cells were stimulated with F(ab’)2 anti-IgM
(Jackson Immunochemicals), whole-cell lysates (WCL) were pre-
pared with 1% NP-40 lysis buffer containing inhibitors, and immuno-
blots and immunoprecipitations were performed as described (Sieh
et al., 1993). Antibodies were directed against phosphoERK (Cell
Signaling), ERK1 (C16) and ERK2 (C14), Lyn, phospho-Lyn (tyrosine
507), and anti-Src (tyrosine 415) (Santa Cruz Biotechnology). Im-
mune complexes were visualized with Western Lightning ECL re-
agent (PerkinElmer Life Sciences, Inc.) and a Kodak Imaging Station.
Calcium Flux
Splenocytes were loaded with 2 mg/1 3 107 cells Fluo3-AM (Molec-
ular Probes), labeled with APC-conjugated antibodies to CD3,
CD11b, Gr1, panNK, and Ter119 (‘‘dump’’), washed, and resus-
pended at 1 3 107 cells/ml. Prewarmed cells were collected at
37ºC on a FACSCalibur for 45 s, stimulated with hen egg lysozyme
(Sigma), goat anti-mouse IgM F(ab’)2 (Jackson Immunochemicals),
or ionomycin, and data collection was continued for 5 min. Staining
a separate aliquot of cells with the APC-labeled dump cocktail and
CD19-perCP indicated that more than 99.8% of the dump2 cells
were CD19+. Data were analyzed with FlowJo (Treestar, Ashland,
OR).
Antibodies and Flow Cytometry
Single-cell suspensions were prepared from peritoneal lavage, LN,
spleen, and bone marrow. Fc receptors were blocked with rat anti-
CD16/CD32 (2.4G2, Harlan). 106 cells were stained with antibodies
directed against CD3, CD19, Mac1, Gr1, IgM, IgD, CD23, Ter119,
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646panNK, CD5, CD43, AA4.1 (eBiosciences) and CD21, IgMa, IgDa,
syndecan, CD1d (BD Biosciences) conjugated to FITC, PE, PerCP,
or APC and analyzed on a FACSCalibur (Becton Dickson).
Immunoglobulin Isotype Enzyme-Linked Immunosorbent Assay
Serum immunoglobulin levels were determined with an immuno-
globulin isotyping kit and standards as per the manufacturer’s pro-
tocol (Southern Biotech).
NPF Immunizations
Mice received intraperitoneal immunizations with 100 mg nitrophenyl
ficoll (NPF) (Biosearch Technologies) in 200 ml PBS or PBS alone.
ELISA plates were coated with 5 mg/ml NPF-BSA (Biosearch Tech-
nologies), nonspecific binding was inhibited with 5% BSA and
0.05% TritonX-100 in PBS, and serially diluted serum samples
were added in duplicate. A standard curve was generated via serial
dilutions of pooled sera from immunized wt mice. NPF-specific Igs
were identified with HRP-conjugated isotype-specific antibodies
(Southern Biotechnology). Data are presented as relative units of
the 1:1000 dilution, which fell in the linear range of the standard
curve, normalized for plate-to-plate variation by including the
same pooled positive and negative sera on each plate.
Stastistical Analyses
Statistical analyses were performed with Prism3 GraphPad software
(San Diego, CA).
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.immunity.com/cgi/content/full/23/6/
635/DC1/.
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